Multiple Myeloma and Other Plasma Cell Neoplasms (Record no. 28997)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02287nam a22003137a 4500 |
001 - CONTROL NUMBER | |
control field | 20241001131259.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | 20241001131259.0 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20241001131741.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 241001b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-3-319-25584-2 |
International Standard Book Number | 978-3-319-25586-6 |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2197-9766 |
International Standard Serial Number | 2197-9774 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | ddc |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.994 15 DIM |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Meletios A. Dimopoulos |
245 ## - TITLE STATEMENT | |
Title | Multiple Myeloma and Other Plasma Cell Neoplasms |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Athens Greece | |
Name of publisher, distributor, etc. | Springer International Publishing Switzerland | |
Date of publication, distribution, etc. | 2018. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 247 Pages |
Extent | Includes References |
490 ## - SERIES STATEMENT | |
Series statement | https://doi.org/10.1007/978-3-319-25586-6 |
Volume/sequential designation | Hematologic Malignancies |
520 ## - SUMMARY, ETC. | |
Summary, etc. | This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Hematology, Immunology, Medical / Clinical Medicine, Medical / Hematology, Medical / Immunology, Medical / Oncology / General, Oncology, Medicine, Medicine and Public Health, Multiple myeloma. |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Fuller form of name | Thierry Facon |
Fuller form of name | Evangelos Terpos |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href=" https://doi.org/10.1007/978-3-319-25586-6 "> https://doi.org/10.1007/978-3-319-25586-6 </a> |
Link text | https://doi.org/10.1007/978-3-319-25586-6 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/01/2024 | 616.994 15 DIM | 20241001131259.0 | 10/01/2024 | 10/01/2024 | E-BOOKS |